The efficacy of remifentanil on the BIS values of patients who are treated with mECT:open-labeled single center non-randomized cross-over trial
Not Applicable
- Conditions
- Psychiatric disorders
- Registration Number
- JPRN-UMIN000010858
- Lead Sponsor
- Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital. Department of Anesthesia.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
ASA PS 4 or 5 history of ischemic heart disease history of heart disease as harmful as ischemic disease allergies or contraindications to medications used in the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the BIS value before the electrical stimulus, the duration of the convulsion
- Secondary Outcome Measures
Name Time Method